(CIDRAP News) The new recommendation to vaccinate children between 6 and 23 months old could have been lost in the hubbub of the influenza vaccine shortage this season. Yet authorities are terming this year's vaccination rates a success story.
(CIDRAP News) Influenza vaccine doses intended for those at highest risk for serious complications from the flu made it into the arms of the right people, the Centers for Disease Control and Prevention (CDC) in Atlanta said yesterday.
(CIDRAP News) Researchers who tracked national data on influenza vaccination rates and mortality in elderly people from 1968 through 2001 say they could find no evidence that flu shots reduced death rates.
(CIDRAP News) A Food and Drug Administration (FDA) advisory committee voted yesterday to add the new A/California strain to next season's influenza vaccine, amid doubts about the nation's ability to acquire an adequate supply.
(CIDRAP News) – The World Health Organization (WHO) is preparing to recommend that governments consider stockpiling vaccines against the H5N1 avian influenza virus now, rather than waiting until a human flu pandemic emerges, according to a story published online today by New Scientist magazine.
(CIDRAP News) – A World Health Organization (WHO) official confirmed today that the agency is working on a report suggesting that governments consider stockpiling H5N1 avian influenza vaccines, but he stressed that such a stockpile "would not solve the problem" if a flu pandemic emerges.
(CIDRAP News) An analysis of 24 studies yielded no clear evidence that influenza vaccines prevent flu in children younger than 2 years old, though they work reasonably well in older children, according to a new report in The Lancet.
(CIDRAP News) – British regulators have cleared Chiron Corp. to resume making influenza vaccine at its plant in Liverpool, England, which should improve the chances of an adequate vaccine supply in the United States next winter.
Three universities have begun recruiting volunteers for the first US clinical trial of a vaccine against H5N1 avian influenza, a key piece of the government's efforts to stave off a potential flu pandemic.